האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

novartis europharm limited - omalizumab - asthma; urticaria - léky na obstrukční onemocnění dýchacích cest, - alergické asthmaxolair je indikován u dospělých, dospívajících a dětí (6 až.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - neoplazmy žaludku - antineoplastická činidla - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

teva b.v. - salmeterol formě solí salmeterol-xinafoátu flutikason-propionát - astma - léky na obstrukční onemocnění dýchacích cest, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - léky na obstrukční onemocnění dýchacích cest, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

roche registration gmbh - satralizumab - neuromyelitis optica - imunosupresiva - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidin - leukemie, myeloidní, akutní - antineoplastická činidla - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 14253 azelastin-hydrochlorid - oční kapky, roztok - 0,5mg/ml - azelastin

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

alk-abelló a/s, horsholm array - 5113 pylovÉ alergeny; 5125 alergeny z roztoČŮ; 16565 alergeny ze srsti domÁcÍch zvÍŘat - injekční suspenze - rŮznÉ alergeny

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

alk-abelló a/s, horsholm array - 5124 hmyzÍ alergeny - injekční suspenze - hmyzÍ alergeny

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

farmak international sp.z.o.o., varšava array - 14253 azelastin-hydrochlorid - nosní sprej, roztok - 1mg/ml - azelastin